Bill Ackman Can Run But he Can’t Escape Valeant Lawsuit

(New York Post) Bill Ackman may have sold his stake in Valeant Pharmaceuticals but he can’t kick the habit as lawsuits continue.

On Wednesday, California US District Judge David Carter permitted Allergan shareholders to pursue their case against Ackman’s Pershing Square and Valeant as a class. The shareholders say that they were cheated out of gains by selling their shares in 2014 while Pershing acquired a nearly 10 percent stake in Allergan to assist Valeant’s now-failed takeover bid of Allergan.

To read this article:

This entry was posted in Syndicated. Bookmark the permalink.

Leave a Reply